추천 제품
material
regenerated cellulose membrane
포장
pkg of 5 Maxi dialysis tubes
용량
0.1-3 mL
튜브 길이 × 직경
8 cm × 2.2 cm
공극 크기
6-8 kDa MWCO
유사한 제품을 찾으십니까? 방문 제품 비교 안내
일반 설명
The Pur-A-Lyzer Dialysis Kits are an innovative dialysis tubing that can be conveniently loaded and unloaded using any standard pipette tip while still allowing for 98% sample recovery yield. The revolutionary design of the Pur-A-Lyzer Tube makes it the only dialysis tool which enables true high throughput dialysis, accommodating a large number of samples in a single buffer tank.
The Pur-A-Lyzer Dialysis Tube allows rapid, high performance extraction of macromolecules without contamination. It is ideal for purification of proteins, automated protein sequencing, peptide mapping and amino acid analysis.
The Pur-A-Lyzer Dialysis Tube allows rapid, high performance extraction of macromolecules without contamination. It is ideal for purification of proteins, automated protein sequencing, peptide mapping and amino acid analysis.
애플리케이션
- Dialysis or buffer exchange of volumes between 10 mL and 20 mL
- Preparation of protein samples for MALDI-MS
- Sample concentration
- Large-scale protein dialysis such as antibodies and recombinant protein purification
- Peptide dialysis for molecules as small as 10 amino acids
- Virus-particle purification
- Removal of contaminating micro molecules
- Purification of tissue culture extracts
- Removal of salts, surfactants, solvents and detergents
- Complex formation studies (protein-protein, protein-DNA and protein-RNA)
- pH and buffer adjustment of sample solution, protein extract or cell extract
- High through- put dialysis, a single beaker can be used for several Pur-A-Lyzer tubes on one floating pad
For your convenience the Pur-A-Lyzer kits come in four sizes:
Mini: 10-250 μL
Midi: 50-800 μL
Maxi: 0.1-3 mL
Mega: 3-20 mL
법적 정보
Pur-A-Lyzer is a trademark of Sigma-Aldrich Co. LLC
가장 최신 버전 중 하나를 선택하세요:
이미 열람한 고객
Frontiers in immunology, 7, 581-581 (2016-12-27)
The devil facial tumor disease (DFTD) is caused by clonal transmissible cancers that have led to a catastrophic decline in the wild Tasmanian devil (Sarcophilus harrisii) population. The first transmissible tumor, now termed devil facial tumor 1 (DFT1), was first
Science advances, 6(27) (2020-09-17)
Around 40% of humans and Tasmanian devils (Sarcophilus harrisii) develop cancer in their lifetime, compared to less than 10% for most species. In addition, devils are affected by two of the three known transmissible cancers in mammals. Immune checkpoint immunotherapy
자사의 과학자팀은 생명 과학, 재료 과학, 화학 합성, 크로마토그래피, 분석 및 기타 많은 영역을 포함한 모든 과학 분야에 경험이 있습니다..
고객지원팀으로 연락바랍니다.